Seymour Pierce

Seymour Pierce was a prominent London-based investment bank and institutional stockbroker that specialized in the small and mid-cap markets, particularly the Alternative Investment Market (AIM). The firm provided a comprehensive suite of services including corporate finance, equity research, and wealth management, with a notable expertise in the healthcare and life sciences sectors. For many years, it served as a leading nominated adviser (NOMAD) and broker for numerous biotechnology and medical technology companies during their initial public offerings and subsequent capital raises. In early 2013, the company entered administration following financial difficulties and regulatory oversight. Its core corporate finance and stockbroking operations were subsequently acquired by Cantor Fitzgerald Europe, which integrated the Seymour Pierce team into its own global operations.